Skip to main content

Sequenom Shares Rise 11 Percent, Luminex Drops

Shares of Sequenom rose 11 percent for the four-day trading period ended Tuesday. Almost all of that increase came after Oppenheimer analyst Sean Lavin on Monday initiated the stock with a “buy” rating. Lavin put an $8 price target on Sequenom’s shares, which were trading at $5.20 on Wednesday afternoon.
 
Luminex led decliners for the week, falling 7.9 percent, though the only news for the week was a distribution pact announced on Tuesday (see Briefs).
 
Overall, the BCW Index dropped .35 percent for the trading week, which was shortened by one day due to the Independence Day holiday last week in the US. In comparison, the Dow Jones Industrial Average declined .6 percent, the Nasdaq fell .2 percent, and the Nasdaq Biotech Index dropped .4 percent.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(July 10, 2007)
Starting Price
(July 3, 2007
)
% change
Affymetrix
AFFX
25.32
25.07
1.00
Agilent
A
39.7
39.68
0.05
Applied Biosystems
ABI
31.17
30.48
2.26
Beckman
BEC
66.77
65.39
2.11
Becton Dickinson
BDX
74.27
75.06
-1.05
Bio-Rad
BIO
75.58
77.15
-2.03
Bruker
BRKR
8.76
9.15
-4.26
Caliper
CALP
4.48
4.6
-2.61
Cepheid
CPHD
14.57
14.75
-1.22
Illumina
ILMN
40.82
41.56
-1.78
Invitrogen
IVGN
74.85
74.59
0.35
Luminex
LMNX
11.75
12.76
-7.92
MDS
MDZ
20.61
20.14
2.33
Millipore
MIL
76.42
76.56
-0.18
PerkinElmer
PKI
26.91
26.71
0.75
Qiagen
QGEN
17.9
18.09
-1.05
Sequenom
SQNM
4.93
4.44
11.04
Sigma-Aldrich
SIAL
42.83
43.16
-0.76
Thermo
TMO
51.77
53.22
-2.72
Third Wave
TWTI
5.97
5.85
2.05
Waters
WAT
60.83
60.5
0.55
BCW Index Average  
36.96
37.09
-0.35
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.